Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 124Precursor Cell Lymphoblastic Leukemia-Lymphoma 76Leukemia 66Myelodysplastic Syndromes 56Lymphoma 34Lymphoma, Non-Hodgkin 33Leukemia, Lymphocytic, Chronic, B-Cell 30Hodgkin Disease 27Leukemia, Myelogenous, Chronic, BCR-ABL Positive 26Burkitt Lymphoma 25Multiple Myeloma 24Lymphoma, Mantle-Cell 19Lymphoma, Follicular 18Hematologic Neoplasms 18Lymphoma, B-Cell, Marginal Zone 17Lymphoma, Large B-Cell, Diffuse 16Leukemia, Biphenotypic, Acute 16Recurrence 15Myeloproliferative Disorders 15Congenital Abnormalities 15Leukemia, Myelomonocytic, Chronic 13Anemia, Refractory, with Excess of Blasts 13Lymphoma, Large-Cell, Immunoblastic 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Blast Crisis 10Graft vs Host Disease 9Neoplasms, Plasma Cell 8Leukemia, Myelomonocytic, Juvenile 8Primary Myelofibrosis 7Leukemia, Myelomonocytic, Acute 7

Interventions

Imatinib Mesylate 4venetoclax 1pevonedistat 1nilotinib 1Watchful Waiting 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Dasatinib 1Cytarabine 1Cladribine 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypereosinophilic Syndrome × Granulocyte Colony-Stimulating Factor × Other hematologic neoplasm × Clear all
NCT00483067 2012-08-02

2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)

M.D. Anderson Cancer Center

Phase 2 Completed
13 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Hypereosinophilic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡